Status:
UNKNOWN
A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
Lead Sponsor:
Shanghai Golden Leaf MedTec Co. Ltd
Conditions:
Liver Cancer
Pancreas Cancer
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
A prospective, multicenter, self-control clinical trial aim to enroll 110 patients suffered from upper abdominal (liver, pancreas, stomach, etc.) cancers . Patients who have taken at least one opioid ...
Eligibility Criteria
Inclusion
- Males or females with ages of 25 to 75;
- Clinically diagnosed as primary or secondary upper abdominal cancers (liver, pancreas, stomach, etc);
- Patients who have taken at least one opioid drug for pain for two weeks and still have VAS pain scale 》6;
- Expected lifetime 》4 months;
- Agrees to take part in the trial and signs the written, informed consent.
Exclusion
- Women who are pregnant, or breast feeding, or having pregancy plan;
- Bleeding tendency or other coagulation related diseases;
- Acute or severe systemic infection;
- Past history of receving denervation procedure in aorta;
- No plans for surgical or interventional procedures in 3 months;
- History of stroke or TIA within 2 weeks;
- Acute coronary events within 2 weeks;
- Other conditions that deem unsuitable for the procedure, in the opinions of investigators.
Key Trial Info
Start Date :
July 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04014478
Start Date
July 15 2019
End Date
July 15 2021
Last Update
July 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.